more

DaVita (DVA)

(Real Time Quote from BATS)

$149.72 USD

-0.24 (-0.16%)

Updated Aug 16, 2024 11:44 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.03%
2	Buy	17.70%
3	Hold	9.37%
4	Sell	5.03%
5	Strong Sell	2.48%
S&P	500	11.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5 2

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

Top 21% (52 out of 251)

Industry: Medical - Outpatient and Home Healthcare

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Founded in 1994 and headquartered in Denver, CO, DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services.

Here's Why You Should Retain Glaukos (GKOS) Stock Right Now

by Zacks Equity Research Published on July 02,2021

Glaukos Corporation (GKOS) continues to benefit from robust product portfolio and solid performing iStent technology.

medical

Amedisys' (AMED) Contessa Buyout to Boost Home Health Business

by Zacks Equity Research Published on July 02,2021

Amedisys (AMED) inks deal to acquire Contessa Health to boost home health and hospice services business.

medical

Abiomed's (ABMD) Impella RP With SmartAssist Gets FDA Nod

by Zacks Equity Research Published on June 30,2021

Abiomed's (ABMD) Impella RP with SmartAssist gets the highest level of approval from the FDA for treatment of right heart failure.

medical

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

by Zacks Equity Research Published on June 30,2021

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, segmental weakness is a woe.

medical

Here's Why You Should Retain Ecolab (ECL) Stock Right Now

by Zacks Equity Research Published on June 29,2021

Ecolab (ECL) continues to gain traction for a solid product portfolio and cost-efficiency program. However, segmental weakness remains a woe.

medical

Fresenius Medical's (FMS) Training Center to Boost Patient Care

by Zacks Equity Research Published on June 29,2021

Fresenius Medical (FMS) inaugurates new training center in Korea to help in the improvement of patient care by offering comprehensive education programs for healthcare professionals.

medical

Here's Why You Should Retain Stryker (SYK) Stock Right Now

by Zacks Equity Research Published on June 23,2021

Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises a concern.

medical

NextGen (NXGN) Partners With Palmetto to Boost Patient Experience

by Zacks Equity Research Published on June 22,2021

NextGen (NXGN) collaborates with Palmetto to enhance patient experience, through the latter's adoption of NextGen RCM Services.

medical

DVA or AMED: Which Is the Better Value Stock Right Now?

by Zacks Equity Research Published on June 21,2021

DVA vs. AMED: Which Stock Is the Better Value Option?

Here's Why You Should Retain Integer Holdings (ITGR) Stock

by Zacks Equity Research Published on June 21,2021

Integer Holdings (ITGR) continues to gain traction from portfolio management.

Zacks.com featured highlights include: Gartner, East West Bancorp, KLA Corp, Landstar System and DaVita

by Zacks Equity Research Published on June 21,2021

Zacks.com featured highlights include: Gartner, East West Bancorp, KLA Corp, Landstar System and DaVita

5 GARP Stocks for a Winning Portfolio

by Zacks Equity Research Published on June 18,2021

Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.

The Zacks Analyst Blog Highlights: UnitedHealth, Encompass Health, Select Medical Holdings and DaVita

by Zacks Equity Research Published on June 18,2021

The Zacks Analyst Blog Highlights: UnitedHealth, Encompass Health, Select Medical Holdings and DaVita

medical

5 Reasons That Make Encompass Health (EHC) an Attractive Bet

by Zacks Equity Research Published on June 17,2021

Encompass Health's (EHC) optimistic business prospects make it a lucrative stock to own for strong gains.

medical

Save Your Portfolio From Inflation With Four Healthcare Stocks

by Zacks Equity Research Published on June 17,2021

Healthcare stocks with long-term growth visibility can be important additions to investment portfolio when inflation runs high.

medical

Here's Why You Should Add DaVita (DVA) Stock to Your Portfolio

by Zacks Equity Research Published on June 17,2021

Investors continue to be optimistic about DaVita (DVA) on its slew of tie-ups and strength in its kidney care business.

medical

Avantor, Inc. (AVTR) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research Published on June 17,2021

Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Here's Why You Should Retain Change Healthcare (CHNG) Stock

by Zacks Equity Research Published on June 16,2021

Change Healthcare (CHNG) continues to benefit from robust payment accuracy business. However, intense competition remains a woe.

medical

Patterson Companies' (PDCO) Unit Completes Miller Vet Buyout

by Zacks Equity Research Published on June 16,2021

Patterson Companies' (PDCO) subsidiary completes acquisition of Miller Vet, which is likely to bolster its Animal Health's presence in the companion animal market.